The uncertainty and anxiety many of us feel right now is normal, but that doesn’t make things easier. Here a few ways to support your well-being during social distancing.

We are not going to let COVID-19 stop cancer care here at the Abramson Cancer Center. Learn about the measures we're taking to ensure your safety and other information about cancer and the coronavirus.

As a cancer patient, it is important to stay adequately nourished to avoid malnutrition. Here are some essential foods to stock in your pantry with while you're practicing social distancing.

In the past few weeks, the Covid-19 pandemic has drastically changed many of our lives. During these uncertain times, it’s important to find ways to manage fear and anxiety to help alleviate day-to-day stressors.

The third and final part of "Let's Get Screened," a three-part series on the Abramson Cancer Center’s efforts to bring breast, colon and lung cancer screenings to residents of our community who most need them. Learn more about the lung cancer screening process and the importance of getting tested.

"Let’s Get Screened" is a three-part series on the Abramson Cancer Center’s efforts to bring breast, colon and lung cancer screenings to residents of our community who most need them. Learn more about the breast cancer screening process and the importance of getting tested.

"Let's Get Screened" is a three-part series on the Abramson Cancer Center’s efforts to bring breast, colon and lung, cancer screenings to residents of our community who most need them. Learn more about the colon cancer screening process and the importance of getting tested.

Megan Roy is a nurse navigator for lung cancer patients at the Abramson Cancer Center. To learn more about her role, check out our interview with Megan.

Before his passing in November 2017, Jason Taylor wrote about his glioblastoma diagnosis and reflected on his cancer journey. A few years after his death, his wife, Alicia wrote about her own experience on caring for a loved one with cancer and moving forward after loss. Read their heartfelt words to learn more about their story.

In 2017, the FDA approved the first cellular therapy for cancer, a living drug called Kymriah, developed at Penn by Dr. Carl June. Learn more about the significance of this new method of therapy and other revolutionary research being conducted at Penn.